136 related articles for article (PubMed ID: 33323743)
1. 18F-FDG and 68Ga-DOTATOC PET/CT Findings in a Case of Abdominal Leiomyosarcoma.
Lorusso M; Angelico G; Quirino M; Scolozzi V; Calcagni ML
Clin Nucl Med; 2021 May; 46(5):e270-e272. PubMed ID: 33323743
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT Findings of Abdominal Leiomyosarcoma.
Güzel Y; Can C; Söğütçü N; Gündeş E; Gündoğan C
Clin Nucl Med; 2021 Dec; 46(12):e594-e597. PubMed ID: 34735413
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTATOC and 18F-FDG PET/CT for identifying the primary lesions of suspected and metastatic neuroendocrine tumors: A prospective study in Taiwan.
Chen SH; Chang YC; Hwang TL; Chen JS; Chou WC; Hsieh CH; Yeh TS; Hsu JT; Yeh CN; Tseng JH; Chen TC; Yen TC
J Formos Med Assoc; 2018 Jun; 117(6):480-487. PubMed ID: 28735662
[TBL] [Abstract][Full Text] [Related]
4. Dual-Tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT Scan and G1-G2 Nonfunctioning Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Evaluation of 124 Nonmetastatic Resected Cases.
Paiella S; Landoni L; Tebaldi S; Zuffante M; Salgarello M; Cingarlini S; D'Onofrio M; Parisi A; Deiro G; Manfrin E; Bianchi B; Montagnini G; Crinò SF; Bassi C; Salvia R
Neuroendocrinology; 2022; 112(2):143-152. PubMed ID: 33508821
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT and 68Ga-DOTATOC PET/CT in Diffuse Pancreatic Neuroendocrine Tumor.
Ji X; Dong A; He Q; Dong H; Zuo C
Clin Nucl Med; 2020 May; 45(5):e245-e248. PubMed ID: 32049733
[TBL] [Abstract][Full Text] [Related]
6. A Case of Brown Tumor on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT.
Yao X; Ou X
Clin Nucl Med; 2022 Jan; 47(1):88-89. PubMed ID: 34874352
[TBL] [Abstract][Full Text] [Related]
7. Multiparametric 18F-FDG and 68GA-DOTATOC PET Imaging in Bone Metastatic Meningioma Before Radionuclide Therapy: Assessment of Tumor Heterogeneity.
Mairal E; Chevalier E; Imbert L; Boursier-Joppin C; Verger A
Clin Nucl Med; 2022 Mar; 47(3):e321-e322. PubMed ID: 35044963
[TBL] [Abstract][Full Text] [Related]
8. Urinary bladder leiomyosarcoma: staging with 18F-FDG PET/CT.
Makis W; Rakheja R; Nahal A; Hickeson M; Lisbona R
Clin Nucl Med; 2013 May; 38(5):e218-22. PubMed ID: 23377410
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performances of 68Ga-DOTATOC versus 18Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumours and interrelationship with histological features.
Lococo F; Rapicetta C; Mengoli MC; Filice A; Paci M; Di Stefano T; Coruzzi C; Versari A
Interact Cardiovasc Thorac Surg; 2019 Jun; 28(6):957-960. PubMed ID: 30753507
[TBL] [Abstract][Full Text] [Related]
10. High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging.
Panagiotidis E; Datseris IE; Exarhos D; Skilakaki M; Skoura E; Bamias A
Nucl Med Commun; 2012 Apr; 33(4):431-8. PubMed ID: 22293498
[TBL] [Abstract][Full Text] [Related]
11. Metastasis From Clear Cell Renal Cell Carcinoma Mimicking Well-Differentiated Pancreatic Neuroendocrine Tumor at 18F-FDG and 68Ga-DOTATOC PET/CT.
Guglielmo P; Pesella F; Sartorello A; El Khouzai B; Berti S; Muccioli S; Gregianin M
Clin Nucl Med; 2022 Jul; 47(7):e498-e499. PubMed ID: 35675141
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids.
Jindal T; Kumar A; Venkitaraman B; Meena M; Kumar R; Malhotra A; Dutta R
Cancer Imaging; 2011 Jun; 11(1):70-5. PubMed ID: 21697027
[TBL] [Abstract][Full Text] [Related]
13. Warthin Tumor Incidentally Detected on PET/CT Showing Both 68Ga-DOTANOC and 18F-FDG Uptake.
Vaz SC; Marques A; Lourenço J; Galzerano A
Clin Nucl Med; 2021 Feb; 46(2):e118-e120. PubMed ID: 32956121
[TBL] [Abstract][Full Text] [Related]
14. MRI and FDG PET/CT Findings of Primary Orbit Leiomyosarcoma.
Zhou W; Hua F; Qian J; Bi Y; Guan Y
Clin Nucl Med; 2017 Jan; 42(1):e71-e74. PubMed ID: 27556798
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the application of 18F-FDG and 68Ga-DOTATATE PET/CT in neuroendocrine tumors: A retrospective study.
Hu X; Li D; Wang R; Wang P; Cai J
Medicine (Baltimore); 2023 May; 102(19):e33726. PubMed ID: 37171344
[TBL] [Abstract][Full Text] [Related]
16. Detection of Adult Pancreatoblastoma by 18F-FDG and 68Ga-DOTATATE PET/MR.
Zhou J; Xie J; Pan Y; Zhang Y
Clin Nucl Med; 2021 Aug; 46(8):671-674. PubMed ID: 33661203
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/MRI in Synchronous Uterine Adenocarcinoma and Leiomyosarcoma.
Yokoo S; Zeng F; Nogami M; Ueno YR; Murakami T
Clin Nucl Med; 2022 Jun; 47(6):e452-e454. PubMed ID: 35353760
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy.
Koukouraki S; Strauss LG; Georgoulias V; Eisenhut M; Haberkorn U; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1115-22. PubMed ID: 16763820
[TBL] [Abstract][Full Text] [Related]
19. Pelvic Leiomyosarcoma With Splenic Metastasis and Response Assessment by 18F-FDG PET/CT.
Yadav D; Kumar R; Rastogi S; Shamim SA
Clin Nucl Med; 2020 Jul; 45(7):547-548. PubMed ID: 32404703
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report.
Liu Y; Zhao X; Zhang J; Wang J; Zhang Z; Dai M; Wang N; Jing F; Wang T; Tian W
Medicine (Baltimore); 2022 Aug; 101(34):e30252. PubMed ID: 36042606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
